Figures & data
Table I. An overview of ubiquitin modifications involved in TGFβ signaling.
Heldin CH, Miyazono K, Ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465–71. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF β receptor for degradation. Mol Cell. 2000;6:1365–75. Kuratomi G, Komuro A, Goto K, Shinozaki M, Miyazawa K, Miyazono K, NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-β (transforming growth factor-β) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-β type I receptor. Biochem J. 2005;386:461–70. Komuro A, Imamura T, Saitoh M, Yoshida Y, Yamori T, Miyazono K, Negative regulation of transforming growth factor-β (TGF-β) signaling by WW domain-containing protein 1 (WWP1). Oncogene. 2004;23:6914–23. Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R. Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci U S A. 2001;98:974–9. Li L, Xin H, Xu X, Huang M, Zhang X, Chen Y, CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol Cell Biol. 2004;24:856–64. Seo SR, Lallemand F, Ferrand N, Pessah M, L'Hoste S, Camonis J, The novel E3 ubiquitin ligase Tiul1 associates with TGIF to target Smad2 for degradation. EMBO J. 2004;23:3780–92. Xin H, Xu X, Li L, Ning H, Rong Y, Shang Y, CHIP controls the sensitivity of transforming growth factor-β signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation. J Biol Chem. 2005;280:20842–50. Fukuchi M, Imamura T, Chiba T, Ebisawa T, Kawabata M, Tanaka K, Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell. 2001;12:1431–43. Soond SM, Chantry A. Selective targeting of activating and inhibitory Smads by distinct WWP2 ubiquitin ligase isoforms differentially modulates TGFβ signalling and EMT. Oncogene. 2011;30:2451–62. Moren A, Imamura T, Miyazono K, Heldin CH, Moustakas A. Degradation of the tumor suppressor Smad4 by WW and HECT domain ubiquitin ligases. J Biol Chem. 2005;280:22115–23. Wan M, Tang Y, Tytler EM, Lu C, Jin B, Vickers SM, Smad4 protein stability is regulated by ubiquitin ligase SCF β-TrCP1. J Biol Chem. 2004;279:14484–7. Liang M, Liang YY, Wrighton K, Ungermannova D, Wang XP, Brunicardi FC, Ubiquitination and proteolysis of cancer-derived Smad4 mutants by SCFSkp2. Mol Cell Biol. 2004;24:7524–37. Bonni S, Wang HR, Causing CG, Kavsak P, Stroschein SL, Luo K, TGF-β induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol. 2001;3:587–95. Bengoechea-Alonso MT, Ericsson J. Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation. Oncogene. 2010;29:5322–8. Hu D, Wan Y. Regulation of Kruppel-like factor 4 by the anaphase promoting complex pathway is involved in TGF-β signaling. J Biol Chem. 2011;286:6890–901. Cheng PL, Lu H, Shelly M, Gao H, Poo MM. Phosphorylation of E3 ligase Smurf1 switches its substrate preference in support of axon development. Neuron. 2011;69:231–43. Lee YS, Park JS, Kim JH, Jung SM, Lee JY, Kim SJ, Smad6-specific recruitment of Smurf E3 ligases mediates TGF-β1-induced degradation of MyD88 in TLR4 signalling. Nat Commun. 2011;2:460. Carpentier I, Coornaert B, Beyaert R. Smurf2 is a TRAF2 binding protein that triggers TNF-R2 ubiquitination and TNF-R2-induced JNK activation. Biochem Biophys Res Commun. 2008;374:752–7. Inui M, Manfrin A, Mamidi A, Martello G, Morsut L, Soligo S, USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat Cell Biol. 2011;13:1368–75. Itoh F, Asao H, Sugamura K, Heldin CH, Ten Dijke P, Itoh S. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads. EMBO J. 2001;20:4132–42. Ibarrola N, Kratchmarova I, Nakajima D, Schiemann WP, Moustakas A, Pandey A, Cloning of a novel signaling molecule, AMSH-2, that potentiates transforming growth factor β signaling. BMC Cell Biol. 2004;5:2. Zhao Y, Thornton AM, Kinney MC, Ma CA, Spinner JJ, Fuss IJ, The deubiquitinase CYLD targets Smad7 to regulate TGF-{β} signaling and the development of regulatory T cells. J Biol Chem. 2011;286:40520–30. Bai Y, Yang C, Hu K, Elly C, Liu YC. Itch E3 ligase-mediated regulation of TGF-β signaling by modulating smad2 phosphorylation. Mol Cell. 2004;15:825–31. Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, Adorno M, FAM/USP9x, a deubiquitinating enzyme essential for TGFβ signaling, controls Smad4 monoubiquitination. Cell. 2009;136:123–35. Sorrentino A, Thakur N, Grimsby S, Marcusson A, von Bulow V, Schuster N, The type I TGF-β receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol. 2008;10:1199–207. Fan YH, Yu Y, Mao RF, Tan XJ, Xu GF, Zhang H, USP4 targets TAK1 to downregulate TNFalpha-induced NF-kappaB activation. Cell Death Differ. 2011;18:1547–60.